Following preliminary clinical
trials, the company is now in discussion with a major New York City hospital to integrate
Fever Smart into a large clinical
research program.
In 2005, Dan co-founded and served as President and CEO of Inviragen Inc., which he transformed from a virtual start - up to a global clinical stage company with sites in Colorado, Wisconsin and Singapore and translated two vaccines from the
research bench to human clinical
trials, including one for dengue
fever.